skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 102  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review
Material Type:
Article
Add to My Research

Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review

International journal of chronic obstructive pulmonary disease, , Vol.15, p.439-460 [Peer Reviewed Journal]

2020 Iheanacho et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Iheanacho et al. 2020 Iheanacho et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/copd.s234942 ;PMID: 32161455

Full text available

2
A tutorial on pilot studies: the what, why and how
Material Type:
Article
Add to My Research

A tutorial on pilot studies: the what, why and how

BMC medical research methodology, 2010-01, Vol.10 (1), p.1-1, Article 1 [Peer Reviewed Journal]

COPYRIGHT 2010 BioMed Central Ltd. ;Copyright ©2010 Thabane et al; licensee BioMed Central Ltd. 2010 Thabane et al; licensee BioMed Central Ltd. ;ISSN: 1471-2288 ;EISSN: 1471-2288 ;DOI: 10.1186/1471-2288-10-1 ;PMID: 20053272

Full text available

3
Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program
Material Type:
Article
Add to My Research

Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program

Journal of clinical epidemiology, 2011-11, Vol.64 (11), p.1187-1197 [Peer Reviewed Journal]

Elsevier Inc. ;2011 Elsevier Inc. ;Copyright © 2011 Elsevier Inc. All rights reserved. ;ISSN: 0895-4356 ;EISSN: 1878-5921 ;DOI: 10.1016/j.jclinepi.2010.08.010 ;PMID: 21477993

Full text available

4
Clinical, economic, and humanistic burden of asthma in Canada: a systematic review
Material Type:
Article
Add to My Research

Clinical, economic, and humanistic burden of asthma in Canada: a systematic review

BMC pulmonary medicine, 2013-12, Vol.13 (1), p.70-70, Article 70 [Peer Reviewed Journal]

COPYRIGHT 2013 BioMed Central Ltd. ;2013 Ismaila et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright © 2013 Ismaila et al.; licensee BioMed Central Ltd. 2013 Ismaila et al.; licensee BioMed Central Ltd. ;ISSN: 1471-2466 ;EISSN: 1471-2466 ;DOI: 10.1186/1471-2466-13-70 ;PMID: 24304726

Full text available

5
Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study
Material Type:
Article
Add to My Research

Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study

Respiratory research, 2018-01, Vol.19 (1), p.19-19, Article 19 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;The Author(s). 2018 ;ISSN: 1465-993X ;ISSN: 1465-9921 ;EISSN: 1465-993X ;DOI: 10.1186/s12931-018-0724-0 ;PMID: 29370819

Full text available

6
Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK
Material Type:
Article
Add to My Research

Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK

International journal of chronic obstructive pulmonary disease, 2023-11, Vol.18, p.2673-2685 [Peer Reviewed Journal]

COPYRIGHT 2023 Dove Medical Press Limited ;ISSN: 1178-2005 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S413947

Full text available

7
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β 2 -Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England
Material Type:
Article
Add to My Research

Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β 2 -Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England

International journal of chronic obstructive pulmonary disease, 2023, Vol.18, p.231 [Peer Reviewed Journal]

2023 Requena et al. ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S389281 ;PMID: 36908830

Full text available

8
Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review
Material Type:
Article
Add to My Research

Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review

International journal of chronic obstructive pulmonary disease, 2020-02, Vol.15, p.417-438 [Peer Reviewed Journal]

2020 Zhang et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Zhang et al. 2020 Zhang et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S234823 ;PMID: 32161454

Full text available

9
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study
Material Type:
Article
Add to My Research

Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study

Respiratory research, 2024-04, Vol.25 (1), p.152-152 [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1465-9921 ;ISSN: 1465-993X ;EISSN: 1465-993X ;DOI: 10.1186/s12931-024-02745-x ;PMID: 38561735

Full text available

10
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study
Material Type:
Article
Add to My Research

Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study

Respiratory research, 2023-09, Vol.24 (1), p.229-229, Article 229 [Peer Reviewed Journal]

2023. BioMed Central Ltd., part of Springer Nature. ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1465-993X ;ISSN: 1465-9921 ;EISSN: 1465-993X ;DOI: 10.1186/s12931-023-02523-1 ;PMID: 37749551

Full text available

11
DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach
Material Type:
Article
Add to My Research

DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach

Advances in therapy, 2023-10, Vol.40 (10), p.4282-4297 [Peer Reviewed Journal]

The Author(s) 2023. corrected publication 2023 ;ISSN: 0741-238X ;EISSN: 1865-8652 ;DOI: 10.1007/s12325-023-02583-1

Digital Resources/Online E-Resources

12
Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom
Material Type:
Article
Add to My Research

Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom

BMC infectious diseases, 2015-10, Vol.15 (1), p.465-465, Article 465 [Peer Reviewed Journal]

COPYRIGHT 2015 BioMed Central Ltd. ;COPYRIGHT 2015 BioMed Central Ltd. ;Copyright BioMed Central 2015 ;Thommes et al. 2015 ;ISSN: 1471-2334 ;EISSN: 1471-2334 ;DOI: 10.1186/s12879-015-1193-4 ;PMID: 26503131

Full text available

13
AHRQ Series Paper 4: Assessing harms when comparing medical interventions: AHRQ and the Effective Health-Care Program
Material Type:
Article
Add to My Research

AHRQ Series Paper 4: Assessing harms when comparing medical interventions: AHRQ and the Effective Health-Care Program

Journal of clinical epidemiology, 2010-05, Vol.63 (5), p.502-512 [Peer Reviewed Journal]

Elsevier Inc. ;2010 Elsevier Inc. ;ISSN: 0895-4356 ;EISSN: 1878-5921 ;DOI: 10.1016/j.jclinepi.2008.06.007 ;PMID: 18823754

Full text available

14
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B2-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study
Material Type:
Article
Add to My Research

Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B2-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study

BMJ open, 2024-02, Vol.14 (2), p.e072361 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-072361 ;PMID: 38326272

Full text available

15
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England
Material Type:
Article
Add to My Research

Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England

International journal of chronic obstructive pulmonary disease, 2023-01, Vol.18, p.1431-1444 [Peer Reviewed Journal]

2023 Requena et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Requena et al. 2023 Requena et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S411437 ;PMID: 37465818

Full text available

16
Correction to: DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach
Material Type:
Article
Add to My Research

Correction to: DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach

Advances in therapy, 2023-10, Vol.40 (10), p.4689-4690 [Peer Reviewed Journal]

Springer Healthcare Ltd., part of Springer Nature 2023 ;ISSN: 0741-238X ;EISSN: 1865-8652 ;DOI: 10.1007/s12325-023-02613-y

Digital Resources/Online E-Resources

17
Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review
Material Type:
Article
Add to My Research

Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review

BMC research notes, 2015-09, Vol.8 (1), p.464-464, Article 464 [Peer Reviewed Journal]

COPYRIGHT 2015 BioMed Central Ltd. ;Copyright BioMed Central 2015 ;Dang-Tan et al. 2015 ;ISSN: 1756-0500 ;EISSN: 1756-0500 ;DOI: 10.1186/s13104-015-1427-y ;PMID: 26391471

Full text available

18
INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
Material Type:
Article
Add to My Research

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice

ERJ open research, 2021-04, Vol.7 (2), p.950 [Peer Reviewed Journal]

Copyright ©The authors 2021. ;Copyright ©The authors 2021 2021 ;ISSN: 2312-0541 ;EISSN: 2312-0541 ;DOI: 10.1183/23120541.00950-2020 ;PMID: 34109236

Full text available

19
Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review
Material Type:
Article
Add to My Research

Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review

International journal of chronic obstructive pulmonary disease, 2023-05, Vol.18, p.719-731 [Peer Reviewed Journal]

2023 Czira et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Czira et al. 2023 Czira et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S394325 ;PMID: 37151760

Full text available

20
Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study
Material Type:
Article
Add to My Research

Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study

International journal of chronic obstructive pulmonary disease, 2023-01, Vol.18, p.2933-2953 [Peer Reviewed Journal]

2023 Czira et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Czira et al. 2023 Czira et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S419119 ;PMID: 38089540

Full text available

Results 1 - 20 of 102  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (100)

Refine My Results

Creation Date 

From To
  1. Before 2008  (5)
  2. 2008 To 2011  (8)
  3. 2012 To 2014  (7)
  4. 2015 To 2018  (19)
  5. After 2018  (63)
  6. More options open sub menu

Resource Type 

  1. Articles  (101)
  2. Books  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait